Cash injection: sovereign funds target healthcare:
"Imagine contact lenses that monitor glucose levels for diabetics, tiny implants to tackle chronic diseases, or algorithms that crunch data to predict illness rates. Rather than science fiction, these are examples of cutting-edge research being pioneered by biotech firms seeking to revolutionize healthcare from cradle to grave. Such work tends to be highly expensive and can take years to pay off -- which makes it a good fit for deep-pocketed sovereign wealth and pension funds that can afford to tie up capital for a long time."
'via Blog this'
Friday, 6 October 2017
Europe's business heads aim to keep Iran nuclear deal despite US threat | World news | The Guardian
Europe's business heads aim to keep Iran nuclear deal despite US threat | World news | The Guardian:
"EU business leaders have said they are prepared to do everything they can to salvage the Iran nuclear deal in the event of a US withdrawal, as the Danish credit agency extended export guarantees to Tehran in the run-up to a showdown with Donald Trump.
The US president has reportedly decided to decertify Iran’s compliance with the landmark nuclear deal next week. On Thursday, he told a meeting of US military leaders that Tehran was not living up to the “spirit of the agreement” and cryptically added they were witnessing “the calm before the storm”."
'via Blog this'
"EU business leaders have said they are prepared to do everything they can to salvage the Iran nuclear deal in the event of a US withdrawal, as the Danish credit agency extended export guarantees to Tehran in the run-up to a showdown with Donald Trump.
The US president has reportedly decided to decertify Iran’s compliance with the landmark nuclear deal next week. On Thursday, he told a meeting of US military leaders that Tehran was not living up to the “spirit of the agreement” and cryptically added they were witnessing “the calm before the storm”."
'via Blog this'
Subscribe to:
Posts (Atom)